why choose us

Clinical Trials Search

Showing 18,890 of 132,963 result(s)
Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB

Status: NOT_YET_RECRUITING

Condition: Age-related Cognitive Decline

Interventions: Forty-two minutes of training on computerized exercises that targets processing speed, memory and attention.

Date: 2022-10-26

Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD

Status: Completed

Condition: End-stage Kidney Disease

Interventions: is a sodium-glucose co-transporter 2 (SGLT2) inhibitor.

Date: 2022-10-26

Identifying Mental Health Distress in EM Physicians

Status: Completed

Condition: Burnout, Professional

Interventions:

The intervention will consist of three components:

  1. Completion of brief text-message based surveys 2-3 times per week
  2. Wearing a w

    Date: 2022-10-26

Blood Pressure Monitoring in Hypertensive Populations: Device Testing, Feasibility, Acceptability

Status: Completed

Condition: Hypertension

Interventions: a novel cuffless continuous BP wrist monitor

Date: 2022-10-26

Methimazole in Patients With Progressive Glioblastoma

Status: Completed

Condition: Glioblastoma

Interventions: Starting dose: Methimazole 15 mg;d.
Six participants will receive this dose.
If they achieve a 10% increase in peripheral blood H2S con

Date: 2022-10-26

Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD)

Status: Completed

Condition: Chronic Granulomatous Disease

Interventions: A monoclonal antibody that targets human CD117

Date: 2022-10-26

Genetic Architecture of Avoidant;Restrictive Food Intake Disorder

Status: Completed

Condition: ARFID

Interventions:

Date: 2022-10-26

Fluoride in Saliva After Use of Fluoride Toothpastes Followed by Fluoride Mouthrinses

Status: COMPLETED

Condition: Dental Caries

Interventions: Participants will brush their teeth with Crest Cavity Protection toothpaste (1,100 ppm F) for 1 minute, expectorate the foam, and rinse their mouths w

Date: 2022-10-26

A Study of Coformulated Favezelimab;Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study

Status: COMPLETED

Condition: Colorectal Cancer

Interventions: Coformulated favezelimab;pembrolizumab (800 mg;200 mg), IV infusion

Date: 2022-10-26

Effect of Allopurinol on Markers of Mineral and Bone Metabolism

Status: COMPLETED

Condition: Chronic Kidney Diseases

Interventions: Allopurinol 100 to 300 mg a day for 3 months

Date: 2022-10-26